Article info
Letter
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet’s disease
- Correspondence to Dr Giuseppe Lopalco, Department of Emergency and Organ Transplantation, Rheumatology Unit, University of Bari, Bari 70124, Italy; glopalco{at}hotmail.it
Citation
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet’s disease
Publication history
- Received March 27, 2019
- Revised July 25, 2019
- Accepted August 6, 2019
- First published August 10, 2019.
Online issue publication
May 12, 2021
Article Versions
- Previous version (12 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.